# Geoffrey Raker

> Geoffrey Raker is a Series A investor at Tailwind Capital backing Health Care and Pharmaceutical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Tailwind Capital](https://shizune.co/investors/profile/tailwind-capital)
- Total investments: 2
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/geoffrey-raker-54a9a481

Geoffrey Raker is a managing director at Tailwind Capital. He is a graduate of Brown University, and of the Harvard Business School.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Pharmaceutical | 2 | 100% |
| Biotechnology | 1 | 50% |
| Online Portals | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Private Equity | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Longs Drug Stores | Longs Drugs Stores is an online pharmacy and health based website. |  | Private Equity |  |  |
| Nautilus Neurosciences | Nautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with relevant products and services that directly benefit those affected by neurological disorders.In the first half of 2010, Nautilus intends to launch a novel product, CAMBIA� (diclofenac potassium for oralsolution).Nautilus is backed by Tailwind Capital, a leading private equity firm that invests in health care, business services and media/communications companies. |  | Series A |  |  |

2 of 2 investments shown.

## About Tailwind Capital

VC Fund · New York, United States

Tailwind focuses on growing middle market companies in the healthcare, business services, and media/communications sectors. They are actively investing their $775 million fund.

5 contacts available at Tailwind Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Bruce Dressel | Operating Executive of Infrastructure Services | https://shizune.co/investors/profile/bruce-dressel-d071 |
| Eash Sundaram | Operating Executive | https://shizune.co/investors/profile/eash-sundaram |
| Andrew Mayer | Partner | https://shizune.co/investors/profile/andrew-mayer |
| Douglas Karp | Managing Partner | https://shizune.co/investors/profile/douglas-karp |
| Geoffrey Raker | Partner | https://shizune.co/investors/profile/geoffrey-s-raker |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Geoffrey Raker invest in?

Geoffrey Raker invests primarily in Health Care, Pharmaceutical and Biotechnology startups, most often at Series A and Private Equity stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co